GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Net Issuance of Debt

Amniotics AB (OSTO:AMNI) Net Issuance of Debt : kr0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Amniotics AB's net issuance of debt for the three months ended in Dec. 2023 was kr0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.


Amniotics AB Net Issuance of Debt Historical Data

The historical data trend for Amniotics AB's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Net Issuance of Debt Chart

Amniotics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
- 1.45 -0.12 14.34 -3.92

Amniotics AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Amniotics AB Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amniotics AB Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Amniotics AB (OSTO:AMNI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 223 63
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.

Amniotics AB (OSTO:AMNI) Headlines

From GuruFocus